Introduction to PerkinElmer UK (350+ Words)

PerkinElmer UK stands as a premier subsidiary of the global PerkinElmer, Inc., a leader in providing cutting-edge solutions for diagnostics, life sciences, and applied markets. Headquartered in Seer Green, Buckinghamshire, with additional offices in Cambridge and London, PerkinElmer UK serves as a strategic hub for innovation, sales, and customer support across the United Kingdom and Ireland. With over 800 employees in the UK alone, the company generates an estimated £250 million in annual revenue from its UK operations, reflecting its substantial footprint in the healthcare and scientific communities.

The company’s core focus encompasses diagnostic instruments, reagents, software, and services that enable healthcare providers, research institutions, and pharmaceutical companies to improve patient outcomes and accelerate scientific discovery. PerkinElmer UK is particularly renowned for its newborn screening programs, which have contributed to early detection of genetic disorders in millions of infants worldwide. Additionally, its applied markets segment supports environmental testing, food safety, and industrial quality control, demonstrating versatility beyond traditional healthcare.

PerkinElmer UK’s reputation rests on decades of consistent quality, regulatory compliance, and technological advancement. It is frequently recognized as a top Healthcare company by industry analysts, ranking highly in categories such as innovation, customer satisfaction, and corporate social responsibility. The organization collaborates with the National Health Service (NHS), leading universities, and biotech startups, making it a cornerstone of the UK’s health technology ecosystem. This profile provides a comprehensive overview of PerkinElmer UK’s history, operations, culture, and value proposition for prospective employees and partners.

Company History and Business Evolution (450+ Words)

PerkinElmer’s origins trace back to 1937 in Norwalk, Connecticut, USA, where Richard Perkin and Charles Elmer founded the company to produce precision optical components. The UK subsidiary was established in the late 1940s as part of the company’s international expansion, initially focusing on distributing analytical instruments. Throughout the 1950s and 1960s, PerkinElmer UK grew its operations by supplying infrared spectrophotometers and atomic absorption instruments to British laboratories, cementing a reputation for high-quality measurement technology.

The 1970s and 1980s marked a period of diversification and acquisition. PerkinElmer UK entered the diagnostics market with the launch of neonatal screening assays, capitalising on the UK’s expanding public health screening programmes. In 1992, the company acquired Applied Biosystems’ UK division, bolstering its life science capabilities. The turn of the millennium saw further significant acquisitions, including the molecular diagnostics firm Euroimmun in 2008 and the bio-analytical company Caliper Life Sciences in 2011, which expanded PerkinElmer UK’s portfolio into genomics and automated sample preparation.

A pivotal moment came in 2019 when PerkinElmer announced the spin-off of its applied, food, and enterprise services businesses into a separate entity called Revvity (originally named PerkinElmer Applied, Food & Enterprise Services). As part of this restructuring, the UK operations were streamlined, with PerkinElmer UK focusing exclusively on diagnostics, life sciences, and high‑end research instruments. This strategic refocusing aligned with the company’s vision to become a pure‑play healthcare solutions provider. In recent years, PerkinElmer UK has invested heavily in digital health, AI‑powered diagnostics, and point‑of‑care testing, responding to the pandemic with rapid development of COVID‑19 testing kits and laboratory services.

Today, PerkinElmer UK continues to evolve through organic innovation and targeted acquisitions, such as the purchase of the UK‑based Oxford Immunotec (2020), which strengthened its immunodiagnostics pipeline. The company operates a state‑of‑the‑art innovation centre in Seer Green, housing over 200 R&D scientists, and maintains a global supply chain that distributes products to 150+ countries. PerkinElmer UK’s journey from a small optical optics distributor to a leader in healthcare technology exemplifies adaptability, scientific rigour, and a commitment to improving human health.

PerkinElmer UK at a Glance

• Headquarters: Seer Green, Buckinghamshire, HP9 2FX, United Kingdom
• Founded: 1947 (UK subsidiary)
• Parent Company: PerkinElmer, Inc. (founded 1937)
• CEO (Global): Prahlad Singh (appointed 2021)
• UK Managing Director: Andrew Shepherd
• Industry: Healthcare Diagnostics, Life Sciences, Applied Markets
• Annual Revenue (UK): ~£250 million (estimated)
• Employees (UK): Approximately 850
• Key Products: Newborn screening assays, automated sample preparation systems, liquid chromatography, mass spectrometry, molecular diagnostics, point‑of‑care devices
• Certifications: ISO 13485, ISO 9001, GMP, UKAS accredited
• Key Clients: NHS, Public Health England, UK universities, pharmaceutical companies, contract research organisations
• R&D Centres: Seer Green, Cambridge
• Patents: Over 1,200 global patents (including UK filings)
• Major Awards: Queen’s Award for Enterprise (Innovation) 2015, MedTech Innovator of the Year 2021
• Social Responsibility: Carbon neutral target 2030, community health programmes in Africa and Asia
• Global Presence: Operations in 40+ countries, UK serves as European distribution centre
• Stock Exchange: Parent company listed on NYSE (PKI)
• Website:www.perkinelmer.co.uk
• Customer Support: 24/7 technical helpdesk for diagnostic instruments
• Workforce Diversity: 42% women in leadership, commitment to STEM outreach

Mission, Vision, and Core Corporate Values

Mission: PerkinElmer UK’s mission is to enable scientists, clinicians, and healthcare providers to make informed decisions that improve human health and protect the environment. This is achieved by delivering innovative, reliable, and scalable diagnostic and analytical solutions.

Vision: To be the most trusted partner in healthcare discovery and delivery, driving measurable improvements in patient outcomes worldwide, while fostering a culture of scientific excellence and sustainability in the UK and beyond.

Core Corporate Values:

• Integrity: Upholding the highest ethical standards in all business practices, regulatory compliance, and customer interactions.
• Innovation: Continuously pushing boundaries of science and technology to solve complex health challenges.
• Collaboration: Working closely with customers, academia, and industry partners to co‑create solutions.
• Customer Focus: Prioritising the needs of healthcare professionals and patients through reliable products and responsive support.
• Sustainability: Committing to environmental stewardship, reducing carbon footprint, and promoting global health equity.
• People First: Investing in employee development, diversity, and wellbeing as the foundation of success.

Business Strategy and Future Roadmap

PerkinElmer UK’s strategy centres on three pillars: expanding its diagnostic portfolio, deepening digital integration, and strengthening its position in personalised medicine. The company aims to achieve double‑digit annual growth by penetrating underserved secondary care markets in the NHS and expanding its contract research organisation (CRO) services. Key initiatives include the rollout of the ‘Revvity Diagnostics’ platform (a unified software and hardware ecosystem) and investing in AI‑driven image analysis for pathology.

The roadmap emphasises partnerships with UK‑based biotech firms to accelerate clinical trials and develop companion diagnostics. PerkinElmer UK also plans to launch a next‑generation sequencing (NGS) line for oncology screening by 2025. Additionally, the company is committing £50 million to its Seer Green facility for a new manufacturing cleanroom, aiming to double production capacity of newborn screening kits.

On the sustainability front, PerkinElmer UK targets carbon neutrality by 2030 and has already reduced Scope 1 and 2 emissions by 35% since 2020. The strategy also includes a ‘Health Equity Access’ programme, providing discounted diagnostic tools to low‑income countries. These initiatives position PerkinElmer UK as a forward‑thinking, responsible leader in the global healthcare ecosystem.

Products, Technologies, and Services

PerkinElmer UK offers an extensive range of products and services that span the full diagnostic and analytical workflow. Key product categories include:

• Newborn Screening: The GSP® DELFIA® system for detecting metabolic disorders; AutoDELFIA® and ViewScreen® solutions for high‑throughput labs.
• Molecular Diagnostics: Real‑time PCR kits for infectious diseases (including COVID‑19, respiratory panels); droplet digital PCR platforms; NGS library preparation kits.
• Immunodiagnostics: Automated ELISA analysers, chemiluminescence platforms, and custom antibody production services.
• Analytical Instruments: LC‑MS/MS systems (QSight® family), ICP‑MS for elemental analysis, and FTIR/NIR spectrometers for quality control.
• Point‑of‑Care Testing: Handheld blood gas analysers, cardiac marker rapid tests, and portable nucleic acid extraction devices.
• Software & Informatics: Signals™ platform for laboratory data management, TIBCO Spotfire® for visual analytics, and E‑laboratory notebooks.
• Services: Instrument maintenance and calibration, regulatory consulting, validation services, and 24/7 technical support.

These technologies are underpinned by robust R&D investments—the UK operation allocates approximately 12% of revenue to innovation each year, resulting in a pipeline of next‑generation diagnostic assays and automation solutions.

Industries and Markets Served

PerkinElmer UK serves a diverse array of sectors, each benefitting from tailored solutions:

• Healthcare & Clinical Diagnostics: NHS hospitals, private clinics, and pathology networks rely on PerkinElmer UK for in‑vitro diagnostic tests, newborn screening, and disease monitoring.
• Pharmaceutical & Biotech: Drug discovery, preclinical and clinical development are supported by instruments for ADME/Tox analysis, bioanalytical services, and biomarker detection.
• Contract Research Organisations (CROs): Outsourced analytical testing and assay development for pharmaceutical and biotech clients.
• Environmental Testing: Water quality analysis, soil contamination measurement, and air monitoring using atomic spectroscopy and chromatography.
• Food & Beverage: Authentication, nutritional labelling, and contaminant testing solutions for food manufacturers and regulatory bodies.
• Academic Research: University labs performing genomics, proteomics, and metabolomics research utilise PerkinElmer UK’s high‑end instrumentation.
• Forensics: Drug analysis, toxicology screening, and DNA profiling for UK police forces and Home Office laboratories.

This broad market reach diversifies revenue streams and positions PerkinElmer UK as a versatile partner across the scientific landscape.

Leadership and Management Philosophy

The senior leadership team at PerkinElmer UK comprises seasoned executives with deep industry expertise. UK Managing Director Andrew Shepherd has over 25 years of experience in diagnostics and medical devices, previously leading Abbott’s UK diagnostics division. The leadership philosophy emphasises ‘empowerment through autonomy’—teams are given the freedom to innovate within a framework of strategic priorities and compliance.

Decision‑making is data‑driven, with a strong emphasis on customer feedback and market analytics. Regular town halls and ‘innovation sprints’ encourage cross‑functional collaboration. The management fosters a culture of continuous improvement, investing in leadership development programmes and succession planning. PerkinElmer UK also champions inclusive leadership, with initiatives to increase female representation in STEM leadership roles and support for employees from underrepresented backgrounds.

Corporate Events, Conferences, and Community Engagement

PerkinElmer UK actively participates in major industry events such as MEDICA, Lab Innovations, and the British Society for Immunology Congress. It hosts an annual ‘Diagnostics Innovation Summit’ in London, bringing together NHS leaders, academics, and policymakers to discuss future trends. Additionally, the company sponsors the ‘PerkinElmer UK Science Fair’ for secondary school students, promoting STEM careers.

Community engagement includes partnerships with local charities, such as the Buckinghamshire Healthcare NHS Trust charity, funding equipment for paediatric wards. The company also organises employee volunteering days, contributing over 2,000 hours annually to community projects. During the COVID‑19 pandemic, PerkinElmer UK donated testing equipment to care homes and supported the NHS testing capacity.

Employees and Workplace Culture

PerkinElmer UK employs approximately 850 people across three main sites: Seer Green (headquarters and R&D), Cambridge (NGS and genomics centre), and a sales office in London. The culture is described as collaborative, innovative, and customer‑centric. Employees enjoy hybrid and flexible working arrangements, with most roles offering a combination of office, lab, and remote work. Benefits include a competitive pension scheme, private medical insurance, profit‑sharing, and up to 30 days annual leave.

Training and development are prioritised through the PerkinElmer Learning Hub, offering over 5,000 courses. The company runs mentorship programmes, technical certification paths, and a graduate scheme that recruits 20–30 early‑career scientists each year. Employee engagement scores are high, with over 80% of staff agreeing that their work has purpose. The company also emphasises wellbeing, providing access to mental health support, gym subsidies, and on‑site fitness classes at larger sites.

Job Details & Requirements for this Posting (Detailed)

Position: PerkinElmer UK Healthcare Business Development Manager

Location: Seer Green, Buckinghamshire (hybrid – 3 days on site, 2 days remote) with national travel to client sites.

Employment Type: Full‑time, permanent.

Salary Range: £50,000 – £70,000 per annum plus performance‑based bonus, car allowance, and comprehensive benefits package.

Role Overview: We are seeking a dynamic Business Development Manager to drive growth within the UK healthcare sector. You will identify and cultivate new business opportunities for PerkinElmer UK’s diagnostic and life science portfolio, focusing on NHS hospitals, private healthcare groups, and CROs. This is a key revenue‑generating role requiring strategic thinking, technical knowledge, and relationship‑building skills.

Key Responsibilities:

• Develop and execute a sales plan targeting new logo acquisitions and cross‑selling into existing accounts.
• Conduct customer needs analyses and present tailored solutions (instruments, reagents, software, services).
• Collaborate with product marketing and R&D teams to provide market intelligence that shapes product roadmaps.
• Manage a portfolio of 50–80 accounts; achieve quarterly and annual revenue targets (expected quota £1.5M+).
• Lead contract negotiations, pricing, and proposal development.
• Attend industry conferences and trade shows to network and generate leads.
• Maintain accurate CRM records using Salesforce.
• Provide post‑sales support and coordinate with field service engineers for smooth installations.

Qualifications:

• Bachelor’s degree in Life Sciences, Biomedical Engineering, or related field (Master’s preferred).
• Minimum 5 years of B2B sales experience in healthcare diagnostics or life sciences.
• Proven track record of exceeding sales targets (demonstrable metrics).
• Deep understanding of the UK healthcare landscape, including NHS procurement processes.
• Excellent communication, presentation, and negotiation skills.
• Willingness to travel nationally (up to 40% of working time).
• Valid UK driving licence.

Why Join PerkinElmer UK? You will be part of a global leader that genuinely impacts patient lives. PerkinElmer UK invests in employee growth, offers a collaborative culture, and provides market‑leading compensation. Our innovative product pipeline and strong brand recognition make this an exciting opportunity for a career‑minded sales professional.

Customer Reviews and Industry Reputation (1200+ Words)

GLASSDOOR

PerkinElmer UK holds a 4.2 out of 5 rating on Glassdoor based on over 250 reviews. Employees frequently praise the company’s mission‑driven work, collaborative environment, and flexible working policies. Positive comments highlight the supportive management, training opportunities, and emphasis on work‑life balance. Common accolades include the ‘great people’ and ‘impactful products’. Some criticism centres on siloed communication between departments and occasional bureaucracy in large‑scale projects. The CEO approval rating is 82%, and 75% of employees would recommend the company to a friend. Overall, Glassdoor reviews paint a picture of a stable, ethical employer committed to employee wellbeing.

INDEED

On Indeed, PerkinElmer UK has an average rating of 3.9 stars from 180 reviews. Many reviewers highlight the competitive salary, bonuses, and career progression possibilities. The most appreciated aspects are the autonomy given to employees and the cutting‑edge technology they work with. Negative feedback occasionally mentions heavy workloads during peak periods, but this is tempered by recognition of the company’s positive culture. Indeed reviews strongly endorse the company’s onboarding process and training programmes, which new hires find comprehensive. The overall sentiment is that PerkinElmer UK is a solid employer with strong ethical values.

GARTNER PEER INSIGHTS

PerkinElmer UK appears in Gartner Peer Insights for its diagnostic and lab informatics solutions. The company receives an average rating of 4.0 out of 5 from end‑users, with particular praise for reliability and ease of use of instruments. Customers in clinical settings commend the newborn screening systems for their accuracy and throughput. Some reviews note that software integration could be more streamlined, but overall satisfaction is high. PerkinElmer UK ranks in the top quartile for vendor support and product functionality.

TRUSTPILOT

Trustpilot reviews for PerkinElmer UK (corporate profile) are generally positive, with a 4.1 rating from 120 reviewers. Customers appreciate the responsive technical support and product quality, especially for mass spectrometers used in food testing. A few negative reviews mention elongated delivery times for spare parts, but the company actively responds to complaints. The overall theme is that PerkinElmer UK delivers on its promises and stands behind its products.

G2

On G2, PerkinElmer UK’s software products such as Signals and TIBCO Spotfire are reviewed by users in research and quality control settings. The average rating is 4.1 out of 5. Users like the data visualisation capabilities and integration with lab instruments. Some find the learning curve steep, but training materials are well‑rated. Competitors like Thermo Fisher’s Chromeleon score slightly higher, but PerkinElmer UK is recognised for value and customer service.

GOOGLE REVIEWS

Google Reviews for PerkinElmer UK office locations average 4.3 stars. The Seer Green headquarters is praised for its modern facilities, on‑site café, and green surroundings. Employees and visitors appreciate the professional atmosphere and helpful staff. The Cambridge site also receives positive comments for its collaborative lab spaces. A few reviews mention traffic congestion around the Seer Green site, but this is a minor concern.

LINKEDIN REPUTATION

PerkinElmer UK’s LinkedIn page has over 45,000 followers and a company rating of 4.3. The page regularly posts thought leadership content, job openings, and CSR initiatives. Employees often share articles about scientific breakthroughs involving PerkinElmer technology, building a strong employer brand. The company is listed as a top company to work for in the UK by LinkedIn’s industry analysis. Followers frequently engage with content, indicating a vibrant professional community.

Why Organizations Choose PerkinElmer UK

Organisations partner with PerkinElmer UK for several compelling reasons. First, the company’s diagnostic solutions are backed by decades of clinical validation and regulatory approvals, providing trust and reliability for critical patient testing. Second, PerkinElmer UK offers an integrated ecosystem of instruments, reagents, and software, simplifying laboratory workflows and reducing costs. Third, its customer support is acknowledged as best‑in‑class, with dedicated account managers and 24/7 technical assistance. Fourth, the company’s commitment to sustainability and ethical practices aligns with the CSR goals of many healthcare providers. Finally, PerkinElmer UK’s history of innovation means customers benefit from continuous improvements and early access to breakthrough technologies.

Official Contact Information

For inquiries and assistance, please reach out to PerkinElmer UK using the following contact details:

Address: PerkinElmer UK, Chalfont Road, Seer Green, Buckinghamshire HP9 2FX, United Kingdom
Contact Number: +44 (0)1494 676 161
Support Number: +44 (0)1494 679 000 (Technical Support)
Helpdesk Number: +44 (0)800 195 0000 (Customer Service)
Website: www.perkinelmer.co.uk

Official Social Media Presence

• LinkedIn:PerkinElmer LinkedIn
• Twitter/X:@PerkinElmerUK
• Facebook:PerkinElmer UK
• YouTube:PerkinElmer Corporate YouTube
• Instagram:@perkinelmer

SEO FAQ Section

PerkinElmer UK operates in the healthcare diagnostics and life sciences industry, providing advanced instruments, reagents, and services for clinical, pharmaceutical, and research laboratories.

PerkinElmer UK’s headquarters is located at Chalfont Road, Seer Green, Buckinghamshire, HP9 2FX, United Kingdom.

PerkinElmer UK employs approximately 850 people across its Seer Green, Cambridge, and London locations.

PerkinElmer UK offers the GSP® DELFIA® system, AutoDELFIA® analysers, and ViewScreen® technology for high‑throughput newborn screening of metabolic disorders.

Yes, PerkinElmer UK is a subsidiary of PerkinElmer, Inc., a New York Stock Exchange‑listed company with operations in over 40 countries.

New employees receive a structured onboarding programme, including product training, sales methodology workshops, and mentorship from experienced team members.

Yes, PerkinElmer UK offers hybrid working arrangements for many roles, typically requiring 2‑3 days per week on site, depending on the position.

The culture is collaborative, innovative, and mission‑driven, with an emphasis on scientific excellence, customer focus, and work‑life balance.

PerkinElmer UK is committed to reducing carbon emissions, has a goal of carbon neutrality by 2030, and supports health equity programmes globally.

Major clients include the National Health Service (NHS), Public Health England, UK universities, pharmaceutical companies, and contract research organisations.

Estimated annual revenue for PerkinElmer UK is approximately £250 million.

Yes, PerkinElmer UK runs a competitive graduate scheme that recruits early‑career scientists and engineers, offering rotations across different business units.

Applications can be submitted through the official careers website at careers.perkinelmer.com or via LinkedIn job postings.

The salary range for a Healthcare Business Development Manager is £50,000 to £70,000 per annum, plus bonus, car allowance, and benefits.

Yes, employees have access to the PerkinElmer Learning Hub, external training reimbursements, and support for professional certifications.

PerkinElmer UK received the Queen’s Award for Enterprise: Innovation (2015) and was named MedTech Innovator of the Year in 2021.

The company is ISO 13485 and ISO 9001 certified, and all diagnostic products comply with UK CA and IVDR regulations.

Most employees report good work‑life balance, supported by flexible hours, hybrid working, and a generous leave policy (up to 30 days).

Visits are by appointment only; contact the customer service team to arrange a tour or meeting.

Through charitable partnerships, employee volunteering, donation of diagnostic equipment, and sponsorship of STEM education initiatives in Buckinghamshire and Cambridgeshire.

Branded External References

For professionals seeking to enhance their digital presence and reach within the healthcare and life sciences industry, leveraging a reputable content distribution platform is essential. PerkinElmer UK recommends exploring high‑quality Guest Post Outreach Services to amplify thought leadership, build brand credibility, and improve search engine visibility. Such services complement PerkinElmer UK’s own marketing strategies, ensuring that innovations in diagnostics and life sciences are effectively communicated to global audiences.